05:00 PM EDT, 03/12/2026 (MT Newswires) -- Harold Bernstein, President, Research and Development, and Chief Medical Officer, on March 10, 2026, sold 30,000 shares in Maze Therapeutics ( MAZE ) for $1,513,560.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1842295/000205017226000015/xslF345X05/form4-03122026_080308.xml